`
M. Calmes et al. / Tetrahedron: Asymmetry 16 (2005) 2173–2178
2177
and the mixture stirred at room temperature until com-
pletion of the hydrolysis (ꢂ5 h) (monitored by HPLC
column A). The organic solvent was removed in vacuo,
after which saturated aqueous NaHCO3 was added and
the mixture extracted with CH2Cl2. The aqueous phase
was acidified (pH 1) and then extracted with CH2Cl2.
The combined organic phases were dried over anhy-
drous Na2SO4 and concentrated in vacuo to afford the
expected acid containing about 5% of the compound
(R)-1 as the saponification was not totally regioselective.
A reverse-phase high performance liquid chromatogra-
phy (column D) yielded the expected pure acid 6.
(CH@), 127.38, 127.85, 127.99, 128.09, 128.51, 128.63
(CH-arom), 130.10 (CH@), 136.52, 138.56 (C-arom),
156.27, 172.52 (CO); HRMS (FAB) Calcd for
C22H25N2O3 (MH+) 365.1865. Found 365.1835.
4.4.2. Compound (1S,2R)-7. Synthesized from com-
pound (1S,2R)-6 (9.2 mg, 0.033 mmol). The benzyl
amide derivative (1S,2R)-7 was obtained as a colourless
oil (11.7 mg, 0.32 mmol, 96% yield, 99% ee); tR (HPLC
column A) 11.7 min; tR (HPLC column C) 21.4 min;
1
MS, H and 13C NMR data are identical to those of
compound (1R,2S)-7:
4.3.1. Compound (1R,2S)-6. Synthesized from com-
pound 4 (250 mg, 0.42 mmol) in THF (4 mL), the acid
(1R,2S)-6 was obtained as a colourless oil (49.6 mg,
4.5. (1R,2S)/(1S,2R)-2-Aminocyclohexane-1-
carboxylic acid 8
20
0.18 mmol, 43% yield, >99% ee); ½aꢀ ¼ þ112 (c 2.3,
The
cis-2-aminocyclohex-3-ene-1-carboxylic
acids
D
CH2Cl2); MS (ESI) m/z: 276.1 [(M+H)+]; tR (HPLC
column A) 10.1 min; 1H NMR (CDCl3): d 2.02 (m,
4H, 2CH2), 2.73 and 2.82 (2br s (80/20), 1H, CHCO),
4.46 and 4.55 (2br s (80/20), 1H, CHNH), 4.96 (d,
J = 12.1, 1H, OHCHC6H5), 5.03 (d, J = 12.1, 1H,
OHCHC6H5), 5.36 (br d, J = 9.3, 1H, NH), 5.56 (br d,
J = 10.0, 1H, CH@); 5.71 (br d, J = 10.0, 1H, CH@),
7.22 (m, 5H, H-arom); 13C NMR (CDCl3): d 22.16,
23.02 (CH2), 43.26 (CHCO), 46.98 (CHNH), 66.97
(OCH2C6H5), 127.17 (CH@), 128.14, 128.36, 128.52
(CH-arom), 129.54 (CHC@), 136.33 (C-arom), 156.11,
178.14 (CO); HRMS (FAB) Calcd for C15H18NO4
(MH+) 276.1236. Found 276.1219.
(1R,2S)-8 and (1S,2R)-8 were obtained by catalytic
hydrogenation of the double bond and hydrogenolysis
of the carbamate group, starting from, respectively
(1R,2S)-6 and (1S,2R)-6, using the synthetic route de-
scribed by Houk et al.9c
The physical properties and chemical characteristics of
2-aminocyclohex-3-ene-1-carboxylic acids (1R,2S)-8
and (1S,2R)-8 are identical to those previously
described.7b,9c
References
4.3.2. Compound (1S,2R)-6. Synthesized from com-
pound 5 (113 mg, 0.19 mmol) in THF (2 mL), the acid
(1S,2R)-6 was obtained as a colourless oil (28 mg,
1. For example, see: (a) Shinagawa, S.; Kanamaru, T.;
Harada, S.; Asai, M.; Okazaki, H. J. Med. Chem. 1987, 30,
1458–1463; (b) Scott, V. R.; Boehme, R.; Matthews, T. R.
Antimicrob. Agents Chemother. 1988, 32, 1154–1160; (c)
Juaristi, E. Enantioselective Synthesis of b-Aminoacids;
Wiley-VCH, John Wiley and Sons: New York, 1997, pp 1–
66; (d) Rowinsky, E. K.; Donehower, R. C. Pharmacol.
Ther. 1991, 52, 35–41; (e) Kawabata, N.; Inamoto, Y.;
Sakane, K.; Iwamoto, T.; Hashimoto, S. J. Antibiot. 1992,
45, 909–912; (f) Guenard, D.; Gueritte-Voegelein, F.;
Potier, P. Acc. Chem. Res. 1993, 26, 160–168; (g) Ojima, I.;
Lin, S.; Wang, T. Curr. Med. Chem. 1999, 6, 927–954; (h)
Lelais, G.; Seebach, D. Biopolymers (Pept. Sci.) 2004, 76,
206–243.
2. For example, see: Mierke, D. F.; No¨ssner, G.; Schillen, P.
W.; Goodman, M. Int. J. Pept. Protein Res. 1990, 35, 35–
41; Hayashi, Y.; Katade, J.; Harada, T.; Tachiki, K.;
Takiguchi, Y.; Maramatsu, M.; Miyazaki, H.; Asari, T.;
Okazaki, T.; Dato, Y.; Yasuda, E.; Tano, M.; Uno, I.;
Ojima, I. J. Med. Chem. 1998, 41, 2345–2360.
20
0.102 mmol, 52% yield, 99% ee); ½aꢀ ¼ ꢁ129 (c 1.0,
D
1
CH2Cl2); tR (HPLC column A) 10.1 min; MS, H and
13C NMR data are identical to those of compound
(1R,2S)-6.
4.4. (1R,2S)/(1S,2R)-2-(Benzyloxycarbonylamino)cyclo-
hex-3-ene-1-benzylcarbamoyle 7
The benzyl amide derivatives (1R,2S)-7 and (1S,2R)-7
were obtained using the synthetic route described by
Corey et al.19 starting, respectively, from (1R,2S)-6
and (1S,2R)-6.
4.4.1. Compound (1R,2S)-7. Synthesized from com-
pound (1R,2S)-6 (10 mg, 0.036 mmol). The benzyl
amide derivative (1R,2S)-7 was obtained as a colourless
oil (12.3 mg, 0.034 mmol, 94% yield, 99% ee); tR (HPLC
column A) 11.7 min; tR (HPLC column C) 17.2 min; SM
3. (a) Gellman, S. H. Acc. Chem. Res. 1998, 31, 173–180; (b)
Park, K.-H.; Kurth, M. J. Tetrahedron 2002, 58, 8629–
8659.
4. Fulo¨p, F. Chem. Rev. 2001, 101, 2181–2204.
¨
5. Appella, D. H.; Christianson, L. A.; Karke, I. L.; Powel,
1
(ESI) m/z: 365.3 [(M+H)+]; H NMR (CDCl3): d 1.59
(m, 1H, HCH), 1.89 (m, 2H, CH2), 2.01 (m, 1H,
HCH), 2.56 (br m, 1H, CHCO), 4.14 (dd, J = 5.7 and
14.8, 1H, HNHCHC6H5), 4.29 (dd, J = 5.7 and 14.8,
1H, HNHCHC6H5), 4.40 (br m, 1H, CHNH), 4.87 (d,
J = 12.3, 1H, OHCHC6H5), 4.93 (d, J = 12.3, 1H,
OHCHC6H5), 5.39 (d, J = 9.3, 1H, NH), 5.57 (m, 1H,
HC@), 5.72 (br d, J = 9.8, 1H, HC@), 6.51 (br s, 1H,
NH), 7.26 (m, 10H, H-arom); 13C NMR (CDCl3): d
21.58, 23.87 (CH2), 43.41 (HNCH2C6H5), 44.24
(CHCO), 46.79 (CHNH), 66.74 (OCH2C6H5), 126.73
D. R.; Gellman, S. H. J. Am. Chem. Soc. 1999, 121, 6206–
6212; Kaman, J.; Forro, E.; Fulo¨p, F. Tetrahedron:
¨
Asymmetry 2000, 11, 1593–1600; Appella, D. H.; Leplae,
P. R.; Raguse, T. L.; Gellman, S. H. J. Org. Chem. 2000,
65, 4766–4769; Berkessel, A.; Glaubitz, K.; Lex, J. Eur. J.
Org. Chem. 2002, 2948–2952.
6. Perlmetter, P.; Rose, M.; Vounatsos, F. Eur. J. Org.
Chem. 2003, 756–760; Gardiner, J.; Anderson, K. H.;
Downard, A.; Abell, A. D. J. Org. Chem. 2004, 69, 3375–
3382.